Systematic Reviews on Bacterial Infections

Follow the links below to find systematic reviews of the evidence for the effectiveness of interventions for bacterial infections.

Reviewed Febuary 2009

Printer friendly page

56 Resources Found
Results 1 to 20 displayed.
1    2    3   
Title:   Skin preparation with alcohol versus alcohol followed by any antiseptic for preventing bacteraemia or contamination of blood for transfusion
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   When blood is collected from blood donors for transfusion it may become contaminated during collection, storage or transfusion. Blood contamination can cause bacteraemia (the presence of bacteria in the blood), severe illness or even death in the blood ...
Date:   Apr 2009
Title:   Antibiotics for treating osteomyelitis in people with sickle cell disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Sickle cell disease affects millions of people throughout the world. Osteomyelitis, a bone infection, is one of the major complications. Antibiotics are given to treat it, but there is no worldwide standard treatment. We searched for randomised controll...
Date:   Apr 2009
Title:   Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Cystic fibrosis is a serious genetic disorder affecting cells in the exocrine glands (sweat glands and others). People with cystic fibrosis have a greater risk of chronic lung infections and intermittently receive courses of antibiotics by injection for...
Date:   Apr 2009
Title:   Interventions for erythema nodosum leprosum
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Leprosy remains a public health issue in poorer parts of the world. In 2007 there were approximately 255,000 new cases reported worldwide. Leprosy (or Hansen's disease) is a chronic infectious disease. The skin and peripheral nerves of people with lepro...
Date:   Mar 2009
Title:   Vaccines for preventing plague
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Plain language summary pending....
Title:   Antibiotic prophylaxis for leptospirosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   This is a systematic review of clinical research testing whether taking the antibiotic can prevent infection from a water-borne bacteria called Leptospira. Data from different trials had conflicting results, and these trials targeted different kinds of ...
Date:   Feb 2009
Title:   Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites, without gastro-intestinal bleeding
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Spontaneous bacterial peritonitis (infection and inflammation of the membrane lining the abdominal cavity) is a frequent complication among cirrhotic patients (patients with end-stage liver disease marked by irreversible scarring of liver tissue) and is...
Date:   Feb 2009
Title:   Probiotics for the treatment of bacterial vaginosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Bacterial vaginosis (BV) is one of the most common causes of genital discomfort in women of reproductive age. This condition occurs when there is an imbalance in the population of normal vaginal micro-organism with depletion of the dominant lactobacilli...
Date:   Jan 2009
Title:   Pneumococcal vaccines for children and adults with bronchiectasis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   In many countries vaccination for the protection against infection of the bacteria pneumococcus, is part of the immunisation schedule for infants as well as, for people with bronchiectasis. In this review, our search for randomised control trials that e...
Date:   Dec 2008
Title:   Single versus combination intravenous antibiotic therapy for people with cystic fibrosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Cystic fibrosis is a serious genetic disease that affects cells in the exocrine glands (sweat glands and others). People with cystic fibrosis have a greater risk of chronic lung infections. They receive antibiotics by injection to treat these. The antib...
Date:   Nov 2008
Title:   Inhaled corticosteroids for cystic fibrosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Post-infection inflammation may contribute to lung damage; long term the most common cause of death in cystic fibrosis (CF). Corticosteroids treat inflammation but may cause adverse effects. These are more severe with oral corticosteroids, but may occur...
Date:   Nov 2008
Title:   Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   People with sickle cell disease (SCD) are especially prone to respiratory infections and blood poisoning. These infections are often caused by pneumococcal bacteria. Infections occur partly due to the spleen not working correctly, but also because damag...
Date:   Oct 2008
Title:   Pneumococcal vaccines for sickle cell disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   People with sickle cell disease are particularly prone to pneumococcal infection, which may be fatal. Children aged up to 23 months are at high risk, but usual polysaccharide pneumococcal vaccines may not work in this age group. New conjugate pneumococc...
Date:   Sep 2008
Title:   Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Chronic infection of the airways by Pseudomonas aeruginosa in people with cystic fibrosis is associated with deterioration in respiratory function. Intravenous antibiotics are the standard therapy for pulmonary exacerbations caused by this micro-organis...
Date:   Aug 2008
Title:   Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Cystic fibrosis is a hereditary disease where thick mucus is produced in the lungs. Pseudomonas aeruginosa and other bacteria cause long-lasting lung infections which result in permanent lung damage. Vaccines aimed at reducing infection with Pseudomonas...
Date:   Aug 2008
Title:   Pneumococcal vaccine for asthma
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Pneumonia is a serious illness for people who have asthma and pneumococcal vaccine has been studied to see if it reduces illness or death in those people. A thorough search for randomised controlled trials of pneumococcal vaccine in asthma has found onl...
Date:   Aug 2008
Title:   Antibiotics for the prophylaxis of bacterial endocarditis in dentistry
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   There is no evidence about whether antibiotic prophylaxis is effective or ineffective against bacterial endocarditis in people at risk who are about to undergo an invasive dental procedure.There is a lack of evidence to support previously published guid...
Date:   Jul 2008
Title:   Interventions for skin changes caused by nerve damage in leprosy
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Three million persons are affected by nerve damage caused by leprosy (Hansen's disease) worldwide. Leprosy is a chronic infectious disease caused by the bacterium Mycobacterium leprae. About 30% of people with leprosy develop nerve damage that can lead ...
Date:   Jul 2008
Title:   Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   The main cause of death in people with cystic fibrosis (CF) is due to chronic lung infection. People with CF now live longer due to the aggressive use of antibiotics to treat lung infections. Traditionally, antibiotics are chosen based on the results of...
Date:   May 2008
Title:   Oral anti-pseudomonal antibiotics for cystic fibrosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Treatment of Pseudomonas aeruginosa (P. aeruginosa) lung infection is of great importance in managing cystic fibrosis lung disease. Oral anti-pseudomonal antibiotics which are as effective and safe as intravenous or nebulised antibiotics would improve t...
Date:   May 2008
Results 1 to 20 displayed.
1    2    3